Skip to main content

Site notifications

Bayer Australia Limited

Regulatory activities for this sponsor.

Sponsor content

17 result(s) found, displaying 1 to 10
  • Kerendia (finerenone) for the treatment of progressive decline of kidney function in adults.
  • Australian prescription medicine decision summary
  • Australian Public Assessment Report for Larotrectinib
  • Australian Public Assessment Report for Darolutamide
  • Australian prescription medicine decision summary
  • Australian Public Assessment Report for Aflibercept (rch)
  • Australian Public Assessment Report for Riociguat
  • Australian Public Assessment Report for Levonorgestrel
  • Australian Public Assessment Report for Regorafenib

Help us improve the Therapeutic Goods Administration site